(138 days)
No
The description mentions "automated overlays" and "automatically generates" but does not provide any details suggesting these functions are driven by AI or ML algorithms. The process described appears to be based on pre-defined anatomical points and user adjustments, rather than learning from data.
No
This device is a software application designed to assist surgeons in planning and reviewing the location of cruciate ligament tunnel insertion sites, not to directly treat a condition or restore a function. It provides visual feedback and guidance for surgical procedures.
No
The device is designed to assist in surgical planning and historical case review of ligament tunnel insertion sites by providing visual feedback and overlays on intraoperative images. It does not diagnose a disease or condition.
No
While the core functionality is software-based, the device description explicitly includes hardware components like a touchscreen computer, keyboard, mouse, video converter, and an optional mobile cart, which are part of the system.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The ACUFEX Director Application Anatomic Guide System is a software-based application that uses intraoperative images from a fluoroscopic C-arm to assist surgeons in planning and reviewing the placement of cruciate ligament tunnels. It works with imaging data and physical positioning aids, not biological samples.
- Intended Use: The intended use clearly states it's designed to help orthopedic surgeons access and use intraoperative images for surgical planning and review. This is an in-vivo application, not in-vitro.
Therefore, the ACUFEX Director Application Anatomic Guide System falls under the category of a medical device used in a surgical setting, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The ACUFEX Director Application Anatomic Guide System is designed to help orthopedic surgeons and specialists access intraoperative images and provides user controlled visual feedback in order to assist in the planning and historical case review of the location of cruciate ligament tunnel insertion sites.
Product codes
OLO
Device Description
The ACUFEX Director Application Anatomic Guide System is a software based application that allows surgeons to captured intraonerative still images from a medical fluoroscopic C-arm, display them on a touchscreen computer, visually locate anatomic landmarks of the tibia or femoral footprint using various automated overlays for ACL/PCL single or double bundle placements and mark the selected tunnel placement based on the anatomic landmarks.
Prior to use of the ACUFEX Director Application Anatomic Guide System the surgeon places a microfracture awl or other radio opaque positioning aid in the desired position for tunnel placement per the surgical procedure.
The ACUFEX Director Application Anatomic Guide System software automatically generates the pre-selected ACL/PCL overlays and places the marker positions on the touchscreen. The surgeon identifies and marks the patient's anatomic locations. These marker locations are relative to the sizing of the grid defined by the surgeon selected ACL or PCL anatomical points. The surgeon can adjust the size or rotate the overlay to accommodate their pre-selected position or they can accept the overlay markers. If the surgeon decides to accept the overlay markers a re-positioning of the microfracture awl relative to the overlay markers is made. At this point the tunnel location can be drilled over the final location of the microfracture awl.
The touchscreen computer is purchased by Smith & Nephew as an "off the self" product. The major components are the touchscreen computer, keyboard, mouse, and video converter. A mobile cart is offered as part of the system or as an optional accessory.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
fluoroscopic C-arm
Anatomical Site
tibia or femoral footprint
Indicated Patient Age Range
Not Found
Intended User / Care Setting
orthopedic surgeons and specialists
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Software verification and validation testing demonstrates that the ACUFEX Director Application Anatomic Guide System does not raise any new questions of safety and efficacy as compared to the predicate device VectorVision ACL cleared in K042512.
Cadaver validation.
The ACUFEX Director Application Anatomic Guide System was tested and met compliance with IEC 60601-1-2, Electro-magnetic Compatibility testing.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.4560 Stereotaxic instrument.
(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).
0
Endoscopy Smith & Nephew. Inc 150 Minuteman Road Andover, MA 01810 USA
T 978-749-1000 F 978-749-1443 www.smith-nephew.com
We are smith&nephew
SECTION IV
KIII843
NOV 1 4 2011
510(k) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION
as required by the Safe Medical Devices Act of 1990 and codified in 21 CFR 807.92 upon which the substantial equivalence is based.
ACUFEX Director Application Anatomic Guide System
Date Prepared: Sept. 9th, 2011
" .
A. Submitter's Name:
. •
Smith & Nephew, Inc., Endoscopy Division 150 Minuteman Road, Andover MA. 01810
B. Company Contact
Janice Haselton
Sr. Regulatory Affairs Specialist
T 978-749-1494
F 978-749-1443
C. Device Name
| Trade Name: | ACUFEX Director Application Anatomic Guide System |
|---|---|
| Common Name: | Anatomic Guide |
| Classification Name: | Orthopedic Stereotaxic Instrument per CFR 882.4560 |
D. Predicate Devices
The Smith & Nephew ACUFEX Director Application Anatomic Guide System is substantially equivalent in Intended Use and Fundamental Scientific Technology to the following legally marketed device in commercial distribution: VectorVision ACL cleared in K042512.
1
E. Description of Device
The ACUFEX Director Application Anatomic Guide System is a software based application that allows surgeons to captured intraonerative still images from a medical fluoroscopic C-arm, display them on a touchscreen computer, visually locate anatomic landmarks of the tibia or femoral footprint using various automated overlays for ACL/PCL single or double bundle placements and mark the selected tunnel placement based on the anatomic landmarks.
Prior to use of the ACUFEX Director Application Anatomic Guide System the surgeon places a microfracture awl or other radio opaque positioning aid in the desired position for tunnel placement per the surgical procedure.
The ACUFEX Director Application Anatomic Guide System software automatically generates the pre-selected ACL/PCL overlays and places the marker positions on the touchscreen. The surgeon identifies and marks the patient's anatomic locations. These marker locations are relative to the sizing of the grid defined by the surgeon selected ACL or PCL anatomical points. The surgeon can adjust the size or rotate the overlay to accommodate their pre-selected position or they can accept the overlay markers. If the surgeon decides to accept the overlay markers a re-positioning of the microfracture awl relative to the overlay markers is made. At this point the tunnel location can be drilled over the final location of the microfracture awl.
The touchscreen computer is purchased by Smith & Nephew as an "off the self" product. The major components are the touchscreen computer, keyboard, mouse, and video converter. A mobile cart is offered as part of the system or as an optional accessory.
F. Intended Use
The ACUFEX Director Application Anatomic Guide System is designed to help orthopedic surgeons and specialists access intraoperative images and provides user controlled visual feedback in order to assist in the planning and historical case review of the location of cruciate ligament tunnel insertion sites.
2
G. Comparison of Technological Characteristics
The proposed ACUFEX Director Application Anatomic Guide System has the following similarities as the predicate device Vector Vision ACL cleared in K042512. In that:
- The proposed and predicate devices both have similar indications for use. .
- The proposed and predicate devices both utilize the same principle of operation. . 1. Computer assisted planning of operative site
- . The proposed and predicate devices both capture diagnostic images for surgeon planning of orthopedic surgery.
- The proposed and predicate devices both use overlays for use in pre-surgical . planning.
The major differences between the ACUFEX Director Application Anatomic Guide System and the VectorVision ACL cleared in K042512 are:
- . The ACUFEX Director Application Anatomic Guide System only provides a still image from the C-arm for viewing on the monitor whereas the VectorVision ACL creates a virtual, individual 3-D surface model of the patient's bone from the patient's intra-operative image
- The ACUFEX Director Application Anatomic Guide System only provides a still . image from the C-arm for viewing on the touchscreen monitor. The VectorVision ACL provides the image using CT, fluoroscopic, x-ray or a MRbased model.
- . The ACUFEX Director Application Anatomic Guide System is a stand-alone system and cannot be connected to the hospital network. The VectorVision ACL can be connected to the hospital network in order to access patient and hospital data.
- The predicate device, VectorVision ACL calibrates the image in order to account . the x-ray's inherent magnification. The ACUFEX Director Application Anatomic Guide System does not need to calibrate since no absolute measurements are needed.
H. Summary Performance Data
- . Software verification and validation testing demonstrates that the ACUFEX Director Application Anatomic Guide System does not raise any new questions of safety and efficacy as compared to the predicate device VectorVision ACL cleared in K042512.
- Cadaver validation. .
The ACUFEX Director Application Anatomic Guide System was tested and met compliance with IEC 60601-1-2, Electro-magnetic Compatibility testing.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle symbol on the right. On the left, the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
NOV 1 4 2011
Smith and Nephew, Inc. Endoscopy Division % Ms. Janice Haselton 150 Minuteman Road Andover, Massachusetts 01810
Re: K111843
Trade/Device Name: ACUFEX Director Application Anatomic Guide System Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic instrument Regulatory Class: Class II Product Code: OLO Dated: November 03, 2011 Received: November 07, 2011
Dear Ms. Haselton:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28. 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act
4
Page 2 – Ms. Janice Haselton
or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours.
Mark N. Melke ንድርጎ የሚገኝ ነው። የጥንተ፡ንጥር ጥናት (ኬሚስትሪ) ነው። የጥንተ፡ንጥር ጥናት (ኬሚስትሪ) ነው። የጥንተ፡ንጥር ጥናት (ኬሚስትሪ) ነው። የጥንተ፡ንጥር ጥናት (ኬሚስትሪ) የጥንተ ( Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number (if known):
KIII 843
Device Name: _________________________________________________________________________________________________________________________________________________________________
Indications For Use:
The ACUFEX Director Application Anatomic Guide System is designed to help orthopedic surgeons and specialists access images intraoperative and provides user controlled visual feedback in order to assist in the planning and historical case review of the location of cruciate ligament tunnel insertion sites.
(Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices
Prescription Use ___________ (Per 21 CFR 801 Subpart D) AND/OR
umber 14111843
Counter Use
(21 CFR 807 Subpart C)
Over-the
(PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)